Korea Investment Corp
BIO icon

Korea Investment Corp’s Bio-Rad Laboratories Class A BIO Stock Holding History

Korea Investment Corp’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,060
Closed -$989K – 703
2025
Q1 		$989K Buy
4,060
+100
+3% +$30.1K ﹤0.01% 699
2024
Q4 		$1.3M Sell
3,960
-100
-2% -$33.9K ﹤0.01% 706
2024
Q3 		$1.36M Sell
4,060
-3,600
-47% -$1.14M ﹤0.01% 708
2024
Q2 		$2.09M Sell
7,660
-5,023
-40% -$1.46M 0.01% 681
2024
Q1 		$4.39M Sell
12,683
-567
-4% -$186K 0.01% 603
2023
Q4 		$4.28M Buy
13,250
+1,616
+14% +$507K 0.01% 609
2023
Q3 		$4.17M Buy
11,634
+3,350
+40% +$1.29M 0.01% 534
2023
Q2 		$3.14M Sell
8,284
-1,033
-11% -$420K 0.01% 598
2023
Q1 		$4.46M Sell
9,317
-608
-6% -$285K 0.01% 551
2022
Q4 		$4.17M Sell
9,925
-1,399
-12% -$565K 0.01% 582
2022
Q3 		$4.72M Sell
11,324
-5,291
-32% -$2.64M 0.01% 562
2022
Q2 		$8.22M Buy
16,615
+4,915
+42% +$2.56M 0.03% 465
2022
Q1 		$6.59M Buy
11,700
+1,600
+16% +$965K 0.02% 526
2021
Q4 		$7.63M Buy
10,100
+4,500
+80% +$3.37M 0.02% 441
2021
Q3 		$4.18M Sell
5,600
-100
-2% -$74.9K 0.01% 547
2021
Q2 		$3.67M Hold
5,700
– – 0.01% 598
2021
Q1 		$3.26M Sell
5,700
-600
-10% -$355K 0.01% 595
2020
Q4 		$3.67M Buy
6,300
+400
+7% +$228K 0.01% 570
2020
Q3 		$3.04M Buy
5,900
+200
+4% +$101K 0.01% 529
2020
Q2 		$2.57M Buy
5,700
+200
+4% +$88.3K 0.01% 556
2020
Q1 		$1.93M Buy
+5,500
New +$2.02M 0.01% 571

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $8.09B AUM 21.95% 1-Year Est. Return

Korea Investment Corp's BIO Position: Q2 2025 in Review

Korea Investment Corp sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 4,060 shares — an estimated $989K sold.

Korea Investment Corp first reported a position in BIO in Q1 2020 and held it in 21 quarters. The position peaked at $8.22M in Q2 2022. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

  • Korea Investment Corp reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
  • Korea Investment Corp sold 4,060 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $989K.
  • Korea Investment Corp first reported a position in Bio-Rad Laboratories Class A in Q1 2020 and held it in 21 quarters.
  • Korea Investment Corp's Bio-Rad Laboratories Class A position peaked at $8.22M in Q2 2022.
  • 384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on Korea Investment Corp's 13F filing for Q2 2025, filed 13 Aug 2025.